Isis Pharmaceuticals (ISIS) Starts ISIS-DMPKRx Phase 1; Receives $14M Milestone
Tweet Send to a Friend
Isis Pharmaceuticals (NASDAQ: ISIS) has initiated a Phase 1 study for ISIS-DMPKRx. Isis earned a $14 million milestone payment ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
